Imagine: Your collaborative research work is about to submitted for publication, but you are not convinced of its scientific validity. The lead author tells you: either you accept her interpretation of results and become co-author, or she kicks you off the paper. Her shady claims will pass peer review and be published, the scientific community as well as clinicians and patients will be misled. You can be part of it, with another paper decorating your CV, or you surrender your data and leave, but this paper is happening.
This is what happened to Jaywant Phopase, principal research engineer at the Linköping University (LiU) in Sweden, who now asks for your advice below. The university is known to readers of my site for the scandal around the fake professor and predatory conference organiser Ashutosh Tiwari. Incidentally, Phopase’s research was originally performed at the same Faculty of Science and Engineering (IFM), where Tiwari found support and protection by the former prefect Ulf Karlsson. Same Karlsson who allegedly used to bully Phopase, exactly because the latter raised a fuss about bad science being published and patients abroad being mistreated.
That science in question was led by former LiU professor May Griffith, then at LiU Faculty of Medicine and Health Sciences (FSM). Griffith’ research project was about artificial corneal implants, made as a composite of a chemical polymer and human collagen, manufactured at LiU and tested for biocompatibility on human subjects in Ukraine and India. For that she was found guilty of research misconduct by “repeated negligence”, in a LiU investigation from 2015 (see LiU press release and the Swedish-language report summary). Continue reading “Linköping researcher protests bad science of corneal implants”
A gang of Indian nanotechnology scientists, allegedly from Annamalai University in India, placed in 2014-2015 several papers in different journals, all of them about nanoparticle synthesis using extracts from various local plants. Most papers went into the journal Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, published by Elsevier. The publications were harshly criticised on PubPeer for their poor science, but also for suspected data manipulations (electron microscopy images, photographs of bacteria dishes and X-ray diffraction measurements were reused across different unrelated papers, see PubPeer examples below).
Five nanotechnology papers at Elsevier are now about to be retracted, at least four of them from Spectrochimica Acta Part A. The concerns about research quality and data integrity may have been however less decisive here. The faculties of the Annamalai University carry no mention of any of these authors as their members, all of the provided corresponding email addresses are from Gmail. A publishing scam, possibly including fraudulent peer review, is the likely reason why these papers are being retracted now. Continue reading “The smelly compost heap of plant-based nanoparticles”
Two seemingly opposing medical editorials on the subject of data sharing have recently been published. One, by the International Committee of Medical Journal Editors (ICMJE) appeared in all of its member journals, a non-paywalled version can be freely read at PLOS Medicine. Its lead author is ICMJE Secretary Darren Taichman, professor of medicine at the University of Pennsylvania. The message goes:
“(ICMJE) believes that there is an ethical obligation to responsibly share data generated by interventional clinical trials because participants have put themselves at risk […]
As a condition of consideration for publication of a clinical trial report in our member journals, the ICMJE proposes to require authors to share with others the deidentified individual-patient data (IPD) underlying the results presented in the article (including tables, figures, and appendices or supplementary material) no later than 6 months after publication”
Continue reading “Research “parasitism” and authorship rights”